Brazil Introduces New Measures To Tackle ‘Judicialization’ Of Access To Medicines
Executive Summary
Brazil has announced new measures to try to deal with the costly problem of patients pursuing access to medicines through the courts.
You may also be interested in...
Brazil Sets Sights On Biogen’s Spinraza For First Risk Sharing Deal
As Brazil turns to risk sharing agreements to improve access to expensive treatments, the health ministry has its eye on Biogen’s rare disease treatment Spinraza (nusinersen).
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.